152 related articles for article (PubMed ID: 19778863)
1. New thrombopoietic growth factors.
Kuter DJ
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S347-56. PubMed ID: 19778863
[TBL] [Abstract][Full Text] [Related]
2. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Desborough M; Hadjinicolaou AV; Chaimani A; Trivella M; Vyas P; Doree C; Hopewell S; Stanworth SJ; Estcourt LJ
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012055. PubMed ID: 27797129
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin receptor agonists: ten years later.
Ghanima W; Cooper N; Rodeghiero F; Godeau B; Bussel JB
Haematologica; 2019 Jun; 104(6):1112-1123. PubMed ID: 31073079
[TBL] [Abstract][Full Text] [Related]
4. New thrombopoietic growth factors.
Kuter DJ
Blood; 2007 Jun; 109(11):4607-16. PubMed ID: 17289815
[TBL] [Abstract][Full Text] [Related]
5. Biology and chemistry of thrombopoietic agents.
Kuter DJ
Semin Hematol; 2010 Jul; 47(3):243-8. PubMed ID: 20620435
[TBL] [Abstract][Full Text] [Related]
6. Molecular insights on Eltrombopag: potential mitogen stimulants, angiogenesis, and therapeutic radioprotectant through TPO-R activation.
Subbarayan R; Srinivasan D; Shadula Osmania S; Murugan Girija D; Ikhlas S; Srivastav N; Balakrishnan R; Shrestha R; Chauhan A
Platelets; 2024 Dec; 35(1):2359028. PubMed ID: 38832545
[TBL] [Abstract][Full Text] [Related]
7. Real-world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study.
Cooper N; Scully M; Percy C; Nicolson PLR; Lowe G; Bagot CN; Thachil J; Grech H; Nokes T; Hill QA; Bradbury C; Talks K; Dutt T; Evans G; Pavord S; Wexler S; Charania A; Collington SJ; Ervin A; Ramscar N; Provan D
Br J Haematol; 2024 Mar; ():. PubMed ID: 38429869
[TBL] [Abstract][Full Text] [Related]
8. Eltrombopag can promote platelet implantation after allogeneic hematopoietic stem cell transplantation as safely and similarly to thrombopoietin.
Li Y; Kong F; Bai G; Jiang Y; Zhang W; Sun X; Sui X; Li Y; Ding M; Yuan D; Wang X; Fang X
Front Immunol; 2024; 15():1340908. PubMed ID: 38650933
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.
Townsley DM; Desmond R; Dunbar CE; Young NS
Int J Hematol; 2013 Jul; 98(1):48-55. PubMed ID: 23690288
[TBL] [Abstract][Full Text] [Related]
10. Clinical indications for thrombopoietin and thrombopoietin-receptor agonists.
Wörmann B
Transfus Med Hemother; 2013 Oct; 40(5):319-25. PubMed ID: 24273485
[TBL] [Abstract][Full Text] [Related]
11. New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents.
Metjian A; Abrams CS
Biologics; 2009; 3():499-513. PubMed ID: 20054440
[TBL] [Abstract][Full Text] [Related]
12. The role of romiplostim for pediatric patients with immune thrombocytopenia.
Al-Samkari H; Grace RF; Kuter DJ
Ther Adv Hematol; 2020; 11():2040620720912992. PubMed ID: 32523658
[TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.
Shen N; Qiao J; Jiang Y; Yan J; Wu R; Yin H; Zhu S; Li J
Biomed Rep; 2024 Mar; 20(3):44. PubMed ID: 38357229
[TBL] [Abstract][Full Text] [Related]
14. Sustained Remission Off-Treatment (SROT) of TPO-RAs: The Burgos Ten-Step Eltrombopag Tapering Scheme.
González-López TJ; Provan D
Medicina (Kaunas); 2023 Mar; 59(4):. PubMed ID: 37109617
[No Abstract] [Full Text] [Related]
15. Combination of two target agonists of the thrombopoietin and thrombopoietin receptor in the treatment of elderly patients with refractory immune thrombocytopenia.
Zhang J; Wang Z; Chen H; Lu X
Cancer Pathog Ther; 2023 Apr; 1(2):154-156. PubMed ID: 38328404
[TBL] [Abstract][Full Text] [Related]
16. Role of thrombopoietin receptor agonists in chemotherapy-induced thrombocytopenia: A meta-analysis.
Gurumurthy G; Kisiel F; Gurumurthy S; Gurumurthy J
J Oncol Pharm Pract; 2023 Dec; ():10781552231219003. PubMed ID: 38155484
[TBL] [Abstract][Full Text] [Related]
17. Novel Perspectives on Thrombopoietin Receptor Agonists Applications.
Stafylidis C; Vlachopoulou D; Syriopoulou S; Chatzidavid S; Viniou NA
Hamostaseologie; 2024 Mar; ():. PubMed ID: 38499186
[TBL] [Abstract][Full Text] [Related]
18. Purification and Activity Evaluation of a Novel Thrombopoietin Mimetic Peptide.
Liang Y; Li Y; Ma R; Duan C
J Pharm Sci; 2024 Feb; 113(2):359-365. PubMed ID: 38006944
[TBL] [Abstract][Full Text] [Related]
19. Peptide immobilized on gold particles enhances cell growth.
Gong J; Ito Y
Cytotechnology; 2008 Nov; 58(3):141-4. PubMed ID: 19137449
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
